Mutual of America Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.51M | Buy |
+182,909
| New | +$8.78M | 0.08% | 257 |
|
|
2026
Q1 | – | Sell |
-193,572
| Closed | -$9.62M | – | 1400 |
|
|
2025
Q4 | $9.62M | Sell |
193,572
-5,687
| -3% | -$277K | 0.1% | 193 |
|
|
2025
Q3 | $9.52M | Sell |
199,259
-13,432
| -6% | -$541K | 0.1% | 201 |
|
|
2025
Q2 | $6.7M | Buy |
212,691
+10,726
| +5% | +$344K | 0.07% | 311 |
|
|
2025
Q1 | $6.61M | Sell |
201,965
-114
| -0.1% | -$4.04K | 0.08% | 292 |
|
|
2024
Q4 | $7.31M | Sell |
202,079
-575
| -0.3% | -$20.2K | 0.08% | 284 |
|
|
2024
Q3 | $6.32M | Sell |
202,654
-75,782
| -27% | -$2.37M | 0.07% | 361 |
|
|
2024
Q2 | $7.45M | Sell |
278,436
-42,484
| -13% | -$1.23M | 0.08% | 260 |
|
|
2024
Q1 | $10.9M | Sell |
320,920
-16,787
| -5% | -$500K | 0.12% | 150 |
|
|
2023
Q4 | $9.77M | Sell |
337,707
-8,408
| -2% | -$223K | 0.11% | 164 |
|
|
2023
Q3 | $9.54M | Sell |
346,115
-1,770
| -0.5% | -$53.9K | 0.12% | 161 |
|
|
2023
Q2 | $10.5M | Sell |
347,885
-4,124
| -1% | -$144K | 0.12% | 150 |
|
|
2023
Q1 | $12.8M | Sell |
352,009
-12,690
| -3% | -$488K | 0.15% | 113 |
|
|
2022
Q4 | $13M | Sell |
364,699
-10,202
| -3% | -$355K | 0.16% | 104 |
|
|
2022
Q3 | $12.7M | Sell |
374,901
-7,843
| -2% | -$255K | 0.17% | 91 |
|
|
2022
Q2 | $11.1M | Buy |
382,744
+16,452
| +4% | +$471K | 0.14% | 120 |
|
|
2022
Q1 | $11.8M | Sell |
366,292
-6,217
| -2% | -$191K | 0.13% | 155 |
|
|
2021
Q4 | $10.9M | Sell |
372,509
-2,823
| -0.8% | -$85.6K | 0.11% | 196 |
|
|
2021
Q3 | $10M | Buy |
375,332
+59,031
| +19% | +$1.58M | 0.1% | 205 |
|
|
2021
Q2 | $9.74M | Sell |
316,301
-34,483
| -10% | -$1.06M | 0.1% | 221 |
|
|
2021
Q1 | $9.18M | Sell |
350,784
-5,441
| -2% | -$152K | 0.1% | 231 |
|
|
2020
Q4 | $8.96M | Sell |
356,225
-2,241
| -0.6% | -$48.2K | 0.1% | 211 |
|
|
2020
Q3 | $7.47M | Sell |
358,466
-23,830
| -6% | -$541K | 0.1% | 210 |
|
|
2020
Q2 | $9.08M | Buy |
382,296
+44,361
| +13% | +$980K | 0.13% | 140 |
|
|
2020
Q1 | $6.08M | Sell |
337,935
-59,094
| -15% | -$1.24M | 0.1% | 223 |
|
|
2019
Q4 | $9.42M | Buy |
397,029
+4,939
| +1% | +$120K | 0.12% | 163 |
|
|
2019
Q3 | $10.8M | Buy |
392,090
+8,073
| +2% | +$239K | 0.15% | 121 |
|
|
2019
Q2 | $12.7M | Sell |
384,017
-36,782
| -9% | -$1.26M | 0.18% | 85 |
|
|
2019
Q1 | $14.7M | Buy |
420,799
+4,806
| +1% | +$179K | 0.21% | 67 |
|
|
2018
Q4 | $13.8M | Buy |
415,993
+54,661
| +15% | +$2.35M | 0.23% | 62 |
|
|
2018
Q3 | $18.2M | Buy |
361,332
+51,776
| +17% | +$2.56M | 0.26% | 49 |
|
|
2018
Q2 | $18.5M | Sell |
309,556
-79,715
| -20% | -$4.13M | 0.28% | 46 |
|
|
2018
Q1 | $17.8M | Sell |
389,271
-1,072
| -0.3% | -$44.7K | 0.28% | 46 |
|
|
2017
Q4 | $15.6M | Sell |
390,343
-12,222
| -3% | -$483K | 0.24% | 57 |
|
|
2017
Q3 | $16.1M | Sell |
402,565
-19,603
| -5% | -$848K | 0.26% | 51 |
|
|
2017
Q2 | $18.2M | Sell |
422,168
-46,876
| -10% | -$1.67M | 0.31% | 42 |
|
|
2017
Q1 | $14.7M | Buy |
469,044
+21,495
| +5% | +$576K | 0.26% | 50 |
|
|
2016
Q4 | $11.3M | Sell |
447,549
-44,725
| -9% | -$999K | 0.21% | 69 |
|
|
2016
Q3 | $12.2M | Sell |
492,274
-54,744
| -10% | -$1.24M | 0.24% | 57 |
|
|
2016
Q2 | $11.1M | Buy |
547,018
+9,425
| +2% | +$167K | 0.24% | 60 |
|
|
2016
Q1 | $8.2M | Sell |
537,593
-1,635
| -0.3% | -$21.3K | 0.18% | 92 |
|
|
2015
Q4 | $7.25M | Sell |
539,228
-29,123
| -5% | -$450K | 0.16% | 111 |
|
|
2015
Q3 | $7.97M | Sell |
568,351
-61,600
| -10% | -$1.15M | 0.19% | 86 |
|
|
2015
Q2 | $10.7M | Sell |
629,951
-93,040
| -13% | -$1.32M | 0.23% | 67 |
|
|
2015
Q1 | $8.74M | Sell |
722,991
-38,724
| -5% | -$366K | 0.19% | 84 |
|
|
2014
Q4 | $6.32M | Buy |
761,715
+20,962
| +3% | +$176K | 0.14% | 150 |
|
|
2014
Q3 | $6.44M | Sell |
740,753
-66,810
| -8% | -$603K | 0.15% | 118 |
|
|
2014
Q2 | $8.84M | Sell |
807,563
-244,587
| -23% | -$2.18M | 0.21% | 69 |
|
|
2014
Q1 | $9.41M | Hold |
1,052,150
| – | – | 0.23% | 58 |
|
|
2013
Q4 | $7.93M | Buy |
1,052,150
+388,793
| +59% | +$2.72M | 0.19% | 82 |
|
|
2013
Q3 | $4.86M | Buy |
663,357
+158,710
| +31% | +$1.07M | 0.13% | 168 |
|
|
2013
Q2 | $3.25M | Buy |
+504,647
| New | +$2.97M | 0.1% | 281 |
|
Other funds holding SUPN
SIMG
SCM
RHJA
Mutual of America Capital Management's SUPN Position: Q2 2026 in Review
Mutual of America Capital Management opened a new position in Supernus Pharmaceuticals (SUPN) in Q2 2026: 182,909 shares worth $8.51M. The stake represents 0.08% of the portfolio and ranks #257 among its holdings. This is a return to the name: Mutual of America Capital Management previously reported a position in SUPN as recently as Q4 2025.
Mutual of America Capital Management first reported a position in SUPN in Q2 2013 and has held it in 52 quarters since. The position peaked at $18.5M in Q2 2018. 173 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.
- Mutual of America Capital Management held 182,909 shares of Supernus Pharmaceuticals worth $8.51M as of Q2 2026.
- Supernus Pharmaceuticals was a new Mutual of America Capital Management position in Q2 2026.
- Supernus Pharmaceuticals made up 0.08% of Mutual of America Capital Management's portfolio in Q2 2026, its #257 holding.
- Mutual of America Capital Management first reported a position in Supernus Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Mutual of America Capital Management's Supernus Pharmaceuticals position peaked at $18.5M in Q2 2018.
- 173 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.
Based on Mutual of America Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.